Mednow to Host a Quarterly Conference Call on Wednesday, June 15, 2022 at 8:30 a.m. EST on its Third Quarter 2022 Financial Results

TORONTO, June 08, 2022–(BUSINESS WIRE)–Mednow Inc. (“Mednow” or the “Company“) (TSXV: MNOW), Canada’s Virtual On-Demand Pharmacy, is pleased to announce that the Company will host its quarterly conference call on Wednesday, June 15, 2022 at 8:30 a.m. EST. The conference call will cover its third quarter of 2022 . financial results.

During the call, the Mednow team will provide an update on Mednow’s expansion, recent strategic partnerships, milestones, M&A activity, and third quarter 2022 financial results. ‘one of the two numbers provided below five minutes before the scheduled start time and specify call Mednow.

Conference call details:
Canada/USA Toll Free: 1-800-319-4610
International number: 1-604-638-5340

The conference call will be available on our website at: https://investors.mednow.ca/financial-reports/

About Mednow Inc.

Mednow is a health technology company providing virtual access with a high standard of care. Designed with accessibility and quality of care in mind, Mednow.ca offers virtual pharmacy and telemedicine services as well as in-home physician visits through an interdisciplinary approach to healthcare focused on the patient experience. . Mednow’s services include free home delivery of medications, a user-friendly interface for easy downloading, transferring and refilling of prescriptions, access to healthcare professionals via an intuitive chat experience, a specialized PillSmart™ system that groups prescriptions and vitamins by date and time and doctor visits.

To learn more, follow Mednow on Facebook, TwitterLinkedIn and Instagram, or visit our website at www.mednow.ca/.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220608005425/en/

contacts

Investor Relations:
Benjamin Ferdinand, Chief Financial Officer
[email protected]
1.855.686.6300

Michael P. Boser